A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants with Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

2024-513848-28-00 Protocol D9440C00003 Human pharmacology (Phase I) - Other Ended

Start 11 Nov 2024 · End 23 Apr 2025 · Status Ended · 2 EU/EEA countries · 3 sites · Protocol D9440C00003

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ended
Participants planned 33
Countries 2
Sites 3

Healthy Volunteers

Key facts

Sponsor
AstraZeneca AB
Participant type
Patients, Healthy volunteers
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Not possible to specify
Trial duration
11 Nov 2024 → 23 Apr 2025
Decision date (initial)
2024-10-28
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Healthy Volunteers

VersionLevelCodeTermSystem organ class
20.0 PT 10068230 Cardiorenal syndrome 100000004849

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

AstraZeneca AB

Sponsor organisation
AstraZeneca AB
Address
-
City
Sodertalje
Postcode
151 85
Country
Sweden

Scientific contact point

Organisation
AstraZeneca AB
Contact name
AstraZeneca Clinical Study Information Centre

Public contact point

Organisation
AstraZeneca AB
Contact name
AstraZeneca Clinical Study Information Centre

Locations

2 EU/EEA countries · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
Bulgaria Ended 13 2
Romania Ended 20 1
Rest of world 0

Investigational sites

Bulgaria

2 sites · Ended
Medical Center Comac Medical Ltd.
NA, Ulitsa Urvich 13, Krasno Selo District, Sofia
Medical Center Comac Medical Ltd.
NA, Ulitsa Sveti Georgi Sofiyski 3, 1606, Sofia

Romania

1 site · Ended
Spitalul Clinic De Nefrologie Dr. Carol Davila
Nephrology, Calea Grivitei Nr 4, 010731, Bucharest

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Bulgaria 2024-11-11 2025-04-23 2024-11-18 2025-04-10
Romania 2024-11-14 2025-04-23 2024-11-20 2025-04-10

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-07-03 Romania Acceptable with conditions
2024-10-21
2024-10-28
2 SUBSTANTIAL MODIFICATION SM-1 2024-11-22 Romania Acceptable
2025-02-10
2025-02-14
3 NON SUBSTANTIAL MODIFICATION NSM-1 2025-03-10 Romania Acceptable
2025-02-10
2025-03-10